Vikas Khemani of Carnelian Capital Advisors discusses the growth potential of the pharma sector and the positive outlook for IT companies like TCS and Infosys. He believes that the underperformance of pharma over the past seven to eight years is coming to an end, with a promising trend emerging in both the US and domestic markets. Khemani also highlights the long-term investment opportunities in the IT sector, particularly with the decline in US interest rates.